Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
New drug could offer another way to treat stroke
Currently in phase 2 trials, BB-031 is the first new mechanistic approach to ischemic stroke treatment in nearly 30 years.
UK clinical trial applications on the rise, finds MHRA
The 9% growth in 2025 could signal that the country is on track to become a more attractive destination for pharamceutical R&D.
Month in pharma news, explained - December 2025
In this monthly news roundup, we take a look back at top moments from the pharmaceutical industry. It’s time to reflect on December 2025.
Pharma's year in review 2025
Hear from three expert voices in an end-of-year round-up as they reflect on the moments that shaped healthcare and life sciences in 2025.
Nine pharma giants sign on to Trump pricing deal
President Donald Trump has unveiled a new set of sweeping pricing deals with nine large drugmakers, according to a White House press release.
GSK signs $17.5m RNA therapeutics pact with CAMP4
GSK has struck the collaboration to accelerate development of RNA-based therapies for neurodegenerative and renal disorders.
Unwrap the best of pharma in 2025
Test your pharma knowledge by playing our Quiz of the Year! Explore the headlines, deals and therapeutic advances that defined 2025.
19 Dec 2025
Unwrap the Best of Healthcare Quiz 2025
Test your clinical knowledge by playing our Quiz of the Year! Explore the breakthroughs, pivotal data and therapeutic advances of 2025.
NICE appoints Prof Jonathan Benger as new CEO
His appointment comes at a pivotal moment for the organisation, as NICE prepares to help deliver the 10 Year Health Plan for the NHS.
1
Mins
16 Dec 2025
Unwrap the Best of Neurology
It’s time for Unwrapped 2025. Explore Neurology’s defining moments, our Word of the Year, and a challenging brain teaser.
←
1
2
3
4
5
6
7
…
68
69
70
→
We’ve noticed you’re accessing
from
North/South America.
View
View